Global MRSA Drugs Market Research Report 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 105

Report ID: 12276

Staphylococcus aureus is a bacteria commonly found on nose or skin of healthy people. MRSA i.e., methicillin-resistant staphylococcus aureus, is thus a type of staphylococcus aureus that is resistant to beta-lactam antibiotic called methicillin. MRSA strains do not respond to methicillin treatment. Around 1% of the population carrying staphylococcus aureus on their nose or skin are infected by MRSA. The infection causes skin and tissue infection, and is transmitted by direct skin-to-skin contact.
Methicillin-resistant Staphylococcus aureus (MRSA) is a skin infection that occurs mostly in hospitals and healthcare facilities. It is treated with commonly-used antibiotics and is highly contagious. This infection is difficult to treat because it is sometimes resistant to commonly-used antibiotics such as methicillin. As per this market research report, the aging people are highly susceptible to MRSA infections, especially in the hospital environment as their weak immune system makes them easily prone to diseases and infections.

The global MRSA Drugs market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on MRSA Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall MRSA Drugs market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
Allergan
Merck
Pfizer
Theravance Biopharma
Absynth Biologics
AmpliPhi Biosciences
AstraZeneca
Basilea Pharmaceutica
Baxter
Cellceutix
Cempra
CrystalGenomics
Debiopharm
Galapagos
GSK
KYORIN Pharmaceutical
Lytix Biopharma
Melinta Therapeutics
Nabriva Therapeutics
NovaDigm Therapeutics

Segment by Regions
North America
Europe
China
Japan

Segment by Type
Tetracycline
Folate antagonist
Cephalosporin
Lipopeptides
Oxazolidinone
Lipoglycopeptide

Segment by Application
Hospital
Research
Clinic
Other

Table of Contents

Executive Summary
1 MRSA Drugs Market Overview
1.1 Product Overview and Scope of MRSA Drugs
1.2 MRSA Drugs Segment by Type
1.2.1 Global MRSA Drugs Production Growth Rate Comparison by Type (2014-2025)
1.2.2 Tetracycline
1.2.3 Folate antagonist
1.2.4 Cephalosporin
1.2.5 Lipopeptides
1.2.6 Oxazolidinone
1.2.7 Lipoglycopeptide
1.3 MRSA Drugs Segment by Application
1.3.1 MRSA Drugs Consumption Comparison by Application (2014-2025)
1.3.2 Hospital
1.3.3 Research
1.3.4 Clinic
1.3.5 Other
1.4 Global MRSA Drugs Market by Region
1.4.1 Global MRSA Drugs Market Size Region
1.4.2 North America Status and Prospect (2014-2025)
1.4.3 Europe Status and Prospect (2014-2025)
1.4.4 China Status and Prospect (2014-2025)
1.4.5 Japan Status and Prospect (2014-2025)
1.5 Global MRSA Drugs Market Size
1.5.1 Global MRSA Drugs Revenue (2014-2025)
1.5.2 Global MRSA Drugs Production (2014-2025)

2 Global MRSA Drugs Market Competition by Manufacturers
2.1 Global MRSA Drugs Production Market Share by Manufacturers (2014-2019)
2.2 Global MRSA Drugs Revenue Share by Manufacturers (2014-2019)
2.3 Global MRSA Drugs Average Price by Manufacturers (2014-2019)
2.4 Manufacturers MRSA Drugs Production Sites, Area Served, Product Types
2.5 MRSA Drugs Market Competitive Situation and Trends
2.5.1 MRSA Drugs Market Concentration Rate
2.5.2 MRSA Drugs Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global MRSA Drugs Production Market Share by Regions
3.1 Global MRSA Drugs Production Market Share by Regions
3.2 Global MRSA Drugs Revenue Market Share by Regions (2014-2019)
3.3 Global MRSA Drugs Production, Revenue, Price and Gross Margin (2014-2019)
3.4 North America MRSA Drugs Production
3.4.1 North America MRSA Drugs Production Growth Rate (2014-2019)
3.4.2 North America MRSA Drugs Production, Revenue, Price and Gross Margin (2014-2019)
3.5 Europe MRSA Drugs Production
3.5.1 Europe MRSA Drugs Production Growth Rate (2014-2019)
3.5.2 Europe MRSA Drugs Production, Revenue, Price and Gross Margin (2014-2019)
3.6 China MRSA Drugs Production (2014-2019)
3.6.1 China MRSA Drugs Production Growth Rate (2014-2019)
3.6.2 China MRSA Drugs Production, Revenue, Price and Gross Margin (2014-2019)
3.7 Japan MRSA Drugs Production (2014-2019)
3.7.1 Japan MRSA Drugs Production Growth Rate (2014-2019)
3.7.2 Japan MRSA Drugs Production, Revenue, Price and Gross Margin (2014-2019)

4 Global MRSA Drugs Consumption by Regions
4.1 Global MRSA Drugs Consumption by Regions
4.2 North America MRSA Drugs Consumption (2014-2019)
4.3 Europe MRSA Drugs Consumption (2014-2019)
4.4 China MRSA Drugs Consumption (2014-2019)
4.5 Japan MRSA Drugs Consumption (2014-2019)

5 Global MRSA Drugs Production, Revenue, Price Trend by Type
5.1 Global MRSA Drugs Production Market Share by Type (2014-2019)
5.2 Global MRSA Drugs Revenue Market Share by Type (2014-2019)
5.3 Global MRSA Drugs Price by Type (2014-2019)
5.4 Global MRSA Drugs Production Growth by Type (2014-2019)

6 Global MRSA Drugs Market Analysis by Applications
6.1 Global MRSA Drugs Consumption Market Share by Application (2014-2019)
6.2 Global MRSA Drugs Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in MRSA Drugs Business
7.1 Allergan
7.1.1 Allergan MRSA Drugs Production Sites and Area Served
7.1.2 MRSA Drugs Product Introduction, Application and Specification
7.1.3 Allergan MRSA Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.1.4 Main Business and Markets Served
7.2 Merck
7.2.1 Merck MRSA Drugs Production Sites and Area Served
7.2.2 MRSA Drugs Product Introduction, Application and Specification
7.2.3 Merck MRSA Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.2.4 Main Business and Markets Served
7.3 Pfizer
7.3.1 Pfizer MRSA Drugs Production Sites and Area Served
7.3.2 MRSA Drugs Product Introduction, Application and Specification
7.3.3 Pfizer MRSA Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.3.4 Main Business and Markets Served
7.4 Theravance Biopharma
7.4.1 Theravance Biopharma MRSA Drugs Production Sites and Area Served
7.4.2 MRSA Drugs Product Introduction, Application and Specification
7.4.3 Theravance Biopharma MRSA Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.4.4 Main Business and Markets Served
7.5 Absynth Biologics
7.5.1 Absynth Biologics MRSA Drugs Production Sites and Area Served
7.5.2 MRSA Drugs Product Introduction, Application and Specification
7.5.3 Absynth Biologics MRSA Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.5.4 Main Business and Markets Served
7.6 AmpliPhi Biosciences
7.6.1 AmpliPhi Biosciences MRSA Drugs Production Sites and Area Served
7.6.2 MRSA Drugs Product Introduction, Application and Specification
7.6.3 AmpliPhi Biosciences MRSA Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.6.4 Main Business and Markets Served
7.7 AstraZeneca
7.7.1 AstraZeneca MRSA Drugs Production Sites and Area Served
7.7.2 MRSA Drugs Product Introduction, Application and Specification
7.7.3 AstraZeneca MRSA Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.7.4 Main Business and Markets Served
7.8 Basilea Pharmaceutica
7.8.1 Basilea Pharmaceutica MRSA Drugs Production Sites and Area Served
7.8.2 MRSA Drugs Product Introduction, Application and Specification
7.8.3 Basilea Pharmaceutica MRSA Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.8.4 Main Business and Markets Served
7.9 Baxter
7.9.1 Baxter MRSA Drugs Production Sites and Area Served
7.9.2 MRSA Drugs Product Introduction, Application and Specification
7.9.3 Baxter MRSA Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.9.4 Main Business and Markets Served
7.10 Cellceutix
7.10.1 Cellceutix MRSA Drugs Production Sites and Area Served
7.10.2 MRSA Drugs Product Introduction, Application and Specification
7.10.3 Cellceutix MRSA Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.10.4 Main Business and Markets Served
7.11 Cempra
7.12 CrystalGenomics
7.13 Debiopharm
7.14 Galapagos
7.15 GSK
7.16 KYORIN Pharmaceutical
7.17 Lytix Biopharma
7.18 Melinta Therapeutics
7.19 Nabriva Therapeutics
7.20 NovaDigm Therapeutics

8 MRSA Drugs Manufacturing Cost Analysis
8.1 MRSA Drugs Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of MRSA Drugs
8.4 MRSA Drugs Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.2 MRSA Drugs Distributors List
9.3 MRSA Drugs Customers

10 Market Dynamics
10.1 Market Trends
10.2 Opportunities
10.3 Market Drivers
10.4 Challenges
10.5 Influence Factors

11 Global MRSA Drugs Market Forecast
11.1 Global MRSA Drugs Production, Revenue Forecast
11.1.1 Global MRSA Drugs Production Growth Rate Forecast (2019-2025)
11.1.2 Global MRSA Drugs Revenue and Growth Rate Forecast (2019-2025)
11.1.3 Global MRSA Drugs Price and Trend Forecast (2019-2025)
11.2 Global MRSA Drugs Production Forecast by Regions (2019-2025)
11.2.1 North America MRSA Drugs Production, Revenue Forecast (2019-2025)
11.2.2 Europe MRSA Drugs Production, Revenue Forecast (2019-2025)
11.2.3 China MRSA Drugs Production, Revenue Forecast (2019-2025)
11.2.4 Japan MRSA Drugs Production, Revenue Forecast (2019-2025)
11.3 Global MRSA Drugs Consumption Forecast by Regions (2019-2025)
11.3.1 North America MRSA Drugs Consumption Forecast (2019-2025)
11.3.2 Europe MRSA Drugs Consumption Forecast (2019-2025)
11.3.3 China MRSA Drugs Consumption Forecast (2019-2025)
11.3.4 Japan MRSA Drugs Consumption Forecast (2019-2025)
11.4 Global MRSA Drugs Production, Revenue and Price Forecast by Type (2019-2025)
11.5 Global MRSA Drugs Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer